Co-Founder and CEO
David leads the AMO team to establish and execute corporate systems, business development, international collaboration, and the overall management of AMO. Dr. Ma’s prior positions include Manager of the Biotechnology Incubation Center at Academia Sinica and Director of Business Development for Medigen Biotechnology Corp. David received his B.Sc. degree in Biochemistry and Molecular Biology from Purdue University (West Lafayette). In 2009, he obtained a Ph.D. in Biomedical Sciences at Washington University in St. Louis.
Co-Founder and CSO
Dr. Huang has worked on crystalline fiber based light sources and their application for 20 years. He invented a new method of high speed cellular-resolution optical coherence tomography for clinical use. Dr. Huang is the distinguished professor at National Taiwan University. He has served as the Chairman/Director of the Graduate Institute of Photonics and Optoelectronics, National Taiwan University and Chairman/Director of the Institute of Electro-Optical Engineering, National Sun Yat-Sen University and has been a guest professor at the Abbe School of Photonics, Friedrich-Schiller University of Jena, Germany. He was the Chairman of the IEEE Photonics Society Taipei Chapter and a steering board member of the European Master of Science in Photonics. Dr. Huang served as a Topical Editor of Optics Letters for 6 years and as Guest Editor for Taiwan Photonics Society Quarterly. He was the recipient of a Ministry of Education Outstanding University/Industry Cooperation Award, 1997, and he and his students have together won several awards, including the Chimei Innovation Excellence Award (2010) and the Optical Communications Elite Award (2005). Dr. Huang received his B.Sc. degree from the Department of Electrical Engineering, National Taiwan University, and his M.Sc. and Ph.D. degrees from the Department of Electrical Engineering, University of Maryland, College Park.
Co-Founder and CTO
Chih-Wei Lu is responsible for the research, product development and regulatory strategy in AMO. He is dedicated to the development of biomedical optics, specializing in optical coherence tomography (OCT). Dr. Lu received his Ph.D. from the Graduate Institute of Photonics and Optoelectronics, National Taiwan University and focused on OCT research. After graduated, he served in the Biomedical Technology and Device Research Labs (BDL), the Industrial Technology Research Institute (ITRI) and the Biomedical Engineer Research and Development Center, National Yang Ming University and led several projects on the development of electro-optical medical devices.
Co-Founder and V.P.
C. Jason Liang is a US patent attorney who has a technology background in chemistry and life science. Before Dr. Liang joined AMO, he worked for several international law firms focusing on helping start-up companies with their IP strategies development and patent portfolio management.
Clinical Development / Associate Director
Emily joined AMO in 2018 and is responsible for strategic planning of international clinical research and supporting operational aspects of clinical studies. Emily Tsai received her PhD in Molecular and Cellular Biology from the University of Pittsburgh. She completed a post-doctoral fellowship at Johns Hopkins University School of Medicine focused on cancer biology. Her past positions include Product Manager at medical device startup company BRAXX and Scientist at Impax Laboratories.
Business Development / Director
David Chang had worked for Medtronic and MicroPort, and medical device distributor company in Taiwan. His previous roles include sales rep., clinical technic support, marketing & market access, and reginal business management. David Chang joined AMO in 2020, and he is responsible for business development, including market channel development, strategy planning, key account management, sales and marketing.
Save time by starting your support request online and we'll connect you to an expert.